Arkolith/Insider Trading/ACST/Form 4

Kavuru Vimal

Director, 10% OwnerAcasti Pharma Inc. (ACST) · full profile →Form 4 · filed Sep 27, 2023
Net Buying
Open-Market Buys
$1.3M
Open-Market Sells
$0
Net Open-Market Flow
$1.3M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 25, 2023Buy(P)676K$1.85$1.3M1.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 25, 2023Buy(P)423K$0.13$55K423K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-018542) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML